Header Logo

Connection

CHRIS AMOS to Polymorphism, Genetic

Back to Details
This is a "connection" page, showing publications CHRIS AMOS has written about Polymorphism, Genetic.
CHRIS AMOS
Connection Strength
1.553
Polymorphism, Genetic
  1. Investigation of inversion polymorphisms in the human genome using principal components analysis. PLoS One. 2012; 7(7):e40224.
    View in: PubMed
    Score: 0.299
  2. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J Clin Invest. 2018 11 01; 128(11):4912-4923.
    View in: PubMed
    Score: 0.115
  3. Functional Variants in Notch Pathway Genes NCOR2, NCSTN, and MAML2 Predict Survival of Patients with Cutaneous Melanoma. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1101-10.
    View in: PubMed
    Score: 0.091
  4. Genome-wide association tests of inversions with application to psoriasis. Hum Genet. 2014 Aug; 133(8):967-74.
    View in: PubMed
    Score: 0.084
  5. Polymorphism in the 5'-flanking region of the insulin gene and its potential relation to cardiovascular disease risk: observations in a biracial community. The Bogalusa Heart Study. Atherosclerosis. 1989 Sep; 79(1):51-7.
    View in: PubMed
    Score: 0.061
  6. Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome. Cancer Causes Control. 2009 Nov; 20(9):1769-77.
    View in: PubMed
    Score: 0.061
  7. Polymorphisms of p21 and p27 jointly contribute to an earlier age at diagnosis of pancreatic cancer. Cancer Lett. 2008 Dec 08; 272(1):32-9.
    View in: PubMed
    Score: 0.057
  8. Influence of methylenetetrahydrofolate reductase gene polymorphisms C677T and A1298C on age-associated risk for colorectal cancer in a caucasian lynch syndrome population. Cancer Epidemiol Biomarkers Prev. 2007 Sep; 16(9):1753-9.
    View in: PubMed
    Score: 0.053
  9. Polymorphisms of FAS and FAS ligand genes involved in the death pathway and risk and progression of squamous cell carcinoma of the head and neck. Clin Cancer Res. 2006 Sep 15; 12(18):5596-602.
    View in: PubMed
    Score: 0.050
  10. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.049
  11. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43.
    View in: PubMed
    Score: 0.048
  12. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res. 2004 Sep 01; 10(17):5845-9.
    View in: PubMed
    Score: 0.043
  13. Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2004 Oct; 25(10):1911-6.
    View in: PubMed
    Score: 0.043
  14. XRCC3 genetic polymorphism, smoking, and lung carcinoma risk in minority populations. Cancer. 2003 Oct 15; 98(8):1701-6.
    View in: PubMed
    Score: 0.041
  15. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis. 2003 Mar; 24(3):505-9.
    View in: PubMed
    Score: 0.039
  16. Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases. Autophagy. 2022 11; 18(11):2519-2536.
    View in: PubMed
    Score: 0.037
  17. Testing for genetic linkage in families by a variance-components approach in the presence of genomic imprinting. Am J Hum Genet. 2002 Mar; 70(3):751-7.
    View in: PubMed
    Score: 0.036
  18. Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J Natl Cancer Inst. 2001 Jul 18; 93(14):1106-8.
    View in: PubMed
    Score: 0.035
  19. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001 Feb 15; 61(4):1354-7.
    View in: PubMed
    Score: 0.034
  20. Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 2000 Jan 15; 60(2):249-52.
    View in: PubMed
    Score: 0.032
  21. The role of germline polymorphisms in the T-cell receptor in susceptibility to ankylosing spondylitis. Br J Rheumatol. 1998 Apr; 37(4):454-8.
    View in: PubMed
    Score: 0.028
  22. Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):13-8.
    View in: PubMed
    Score: 0.027
  23. Polymorphisms in MicroRNAs are associated with survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2503-11.
    View in: PubMed
    Score: 0.022
  24. Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers. Hum Genet. 2011 Dec; 130(6):789-94.
    View in: PubMed
    Score: 0.017
  25. Estimating the power of linkage analysis in hereditary breast cancer. Am J Hum Genet. 1990 Feb; 46(2):266-72.
    View in: PubMed
    Score: 0.016
  26. CTLA4/ICOS gene variants and haplotypes are associated with rheumatoid arthritis and primary biliary cirrhosis in the Canadian population. Arthritis Rheum. 2009 Apr; 60(4):931-7.
    View in: PubMed
    Score: 0.015
  27. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2393-401.
    View in: PubMed
    Score: 0.014
  28. Aurora-A and p16 polymorphisms contribute to an earlier age at diagnosis of pancreatic cancer in Caucasians. Clin Cancer Res. 2007 May 15; 13(10):3100-4.
    View in: PubMed
    Score: 0.013
  29. p73 G4C14-to-A4T14 polymorphism and risk of lung cancer. Cancer Res. 2004 Oct 01; 64(19):6863-6.
    View in: PubMed
    Score: 0.011
  30. GSTM1 polymorphism does not affect hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):676-8.
    View in: PubMed
    Score: 0.011
  31. The worldwide distribution of the VHL 598C>T mutation indicates a single founding event. Blood. 2004 Mar 01; 103(5):1937-40.
    View in: PubMed
    Score: 0.010
  32. p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity. J Natl Cancer Inst. 2002 May 01; 94(9):681-90.
    View in: PubMed
    Score: 0.009
  33. Common deletion of SMAD4 in juvenile polyposis is a mutational hotspot. Am J Hum Genet. 2002 May; 70(5):1357-62.
    View in: PubMed
    Score: 0.009
  34. The association of microsomal epoxide hydrolase polymorphisms and lung cancer risk in African-Americans and Mexican-Americans. Carcinogenesis. 2001 Jun; 22(6):923-8.
    View in: PubMed
    Score: 0.009
  35. Testing for linkage under robust genetic models. Hum Hered. 1999 Jun; 49(3):146-53.
    View in: PubMed
    Score: 0.008
  36. Deletion in poly(ADP-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis. 1998 Jan; 19(1):93-8.
    View in: PubMed
    Score: 0.007
  37. Strain difference in jejunal crypt cell susceptibility to radiation-induced apoptosis. Int J Radiat Biol. 1996 Nov; 70(5):579-85.
    View in: PubMed
    Score: 0.006
  38. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis. 1995 Sep; 16(9):2205-8.
    View in: PubMed
    Score: 0.006
  39. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine. Henry Ford Hosp Med J. 1989; 37(3-4):109-11.
    View in: PubMed
    Score: 0.004
  40. Association between polymorphic blood markers and risk factors for cardiovascular disease in a large pedigree. Genet Epidemiol. 1987; 4(4):267-75.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.